Modeling using discrete event simulation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--4. MJ Karnon J, Stahl J, Brennan A, Caro JJ, Mar J, ISMGRPT Force Value in Health. 15 (6), 821-827, 2012 | 556* | 2012 |
Modeling using discrete event simulation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--4. MJ Karnon J, Stahl J, Brennan A, Caro JJ, Mar J, ISMGRPT Force Value in Health 15 (6), 821-827, 2012 | 556* | 2012 |
Modeling using discrete event simulation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force–4 J Karnon, J Stahl, A Brennan, JJ Caro, J Mar, J Möller Medical decision making 32 (5), 701-711, 2012 | 556 | 2012 |
Modeling using discrete event simulation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force–4 J Karnon, J Stahl, A Brennan, JJ Caro, J Mar, J Möller Medical decision making 32 (5), 701-711, 2012 | 556 | 2012 |
Propuesta de guía para la evaluación económica aplicada a las tecnologías sanitarias J López Bastida, J Oliva, F Antoñanzas, A García-Altés, R Gisbert, J Mar, ... Gaceta Sanitaria 24 (2), 154-170, 2010 | 342 | 2010 |
Spanish recommendations on economic evaluation of health technologies J López-Bastida, J Oliva, F Antonanzas, A García-Altés, R Gisbert, J Mar, ... The European Journal of Health Economics 11 (5), 513-520, 2010 | 266 | 2010 |
Which is more important for the efficiency of hypertension treatment: hypertension stage, type of drug or therapeutic compliance? J Mar, F Rodríguez-Artalejo Journal of hypertension 19 (1), 149-155, 2001 | 156 | 2001 |
The cost-effectiveness of nCPAP treatment in patients with moderate-to-severe obstructive sleep apnoea J Mar, JR Rueda, J Durán-Cantolla, C Schechter, J Chilcott European Respiratory Journal 21 (3), 515-522, 2003 | 141 | 2003 |
The impact of acquired brain damage in terms of epidemiology, economics and loss in quality of life J Mar, A Arrospide, JM Begiristain, I Larrañaga, E Elosegui, ... BMC neurology 11, 1-11, 2011 | 120 | 2011 |
Economic impact of patients admitted to stroke units in Spain J Alvarez-Sabín, M Quintana, J Masjuan, J Oliva-Moreno, J Mar, ... The European Journal of Health Economics 18, 449-458, 2017 | 112 | 2017 |
Determinants of Informal Care, Burden, and Risk of Burnout in Caregivers of Stroke Survivors: The CONOCES Study J Oliva-Moreno, LM Peña-Longobardo, J Mar, J Masjuan, S Soulard, ... Stroke 49 (1), 140-146, 2018 | 104 | 2018 |
El síndrome de apneas-hipopneas durante el sueño en España. Disponibilidad de recursos para su diagnóstico y tratamiento en los hospitales del Estado español J Durán-Cantolla, J Mar, GLT Muñecas, RR Aramendi, L Guerra Archivos de Bronconeumología 40 (6), 259-267, 2004 | 102 | 2004 |
A proposed guideline for economic evaluation of health technologies JB López, J Oliva, F Antoñanzas, A García-Altés, R Gisbert, J Mar, ... Gaceta sanitaria 24 (2), 154-170, 2010 | 98 | 2010 |
Cost-effectiveness analysis of thrombolytic treatment for stroke J Mar, JM Begiristain, A Arrazola Cerebrovascular Diseases 20 (3), 193-200, 2005 | 90 | 2005 |
Cost-effectiveness analysis of sofosbuvir-based regimens for chronic hepatitis C R San Miguel, V Gimeno-Ballester, A Blázquez, J Mar Gut 64 (8), 1277-1288, 2015 | 74 | 2015 |
Efectividad de una intervención preoperatoria de enfermería sobre el control de la ansiedad de los pacientes quirúrgicos E Díez-Álvarez, A Arrospide, J Mar, U Alvarez, A Belaustegi, B Lizaur, ... Enfermería clínica 22 (1), 18-26, 2012 | 74 | 2012 |
Budget impact analysis of thrombolysis for stroke in Spain: a discrete event simulation model J Mar, A Arrospide, M Comas Value in health 13 (1), 69-76, 2010 | 68 | 2010 |
Discrete‐Event Simulation Applied to Analysis of Waiting Lists. Evaluation of a Prioritization System for Cataract Surgery M Comas, X Castells, L Hoffmeister, R Román, F Cots, J Mar, ... Value in health 11 (7), 1203-1213, 2008 | 64 | 2008 |
Los costes del ictus en España según su etiología. El protocolo del estudio CONOCES J Mar, J Álvarez-Sabín, J Oliva, V Becerra, MA Casado, M Yébenes, ... Neurología 28 (6), 332-339, 2013 | 59 | 2013 |
Coste de la enfermedad cerebrovascular aguda JM Beguiristain, J Mar, A Arrazola Rev neurol 40 (7), 406-411, 2005 | 59* | 2005 |